Showing results (1391-1400 of 6,507) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|March 13, 2023
Anti-PD-1 therapy in advanced sarcomas: is cutaneous primary site a stronger predictor of response than histologic subtype?Ruoyu Miao, Jennifer Swank, Dan Melzer, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2022
Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysisÁdám Széles, Tamás Fazekas, Szilard Váncsa, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2022
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft modelJaya Lakshmi Thangaraj, Sung-Hoon Jung, Manh-Cuong Vo, et al.
Cancer Immunology, Immunotherapy : CII|November 21, 2025
Early trajectory of inflammatory cytokines following tarlatamab administration in three advanced SCLC patientsTakuma Imakita, Kohei Fujita, Yuki Yamamoto, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2025
The FSTL1-DIP2A axis is a significant biomarker for predicting anti-PD1 therapeutic efficacy in advanced gastric cancerChie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima, et al.
Cancer Immunology, Immunotherapy : CII|November 12, 2025
Sustained remission with PD-1 and BTK inhibitors maintenance after chimeric antigen receptor T-cell therapy in CNS lymphomaLingzi Yu, Nana Ping, Rui Zou, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2026
Unaltered NKG2D-CAR T cell function under hypoxia in osteosarcoma in vitroLaura Hidalgo, Patricia Garcia-Rodriguez, Isabel Cubillo, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2025
Biology and evolving management of resectable dMMR/MSI-H cancers: current status and future perspectivesTokiyoshi Tanegashima, Masaki Shiota, Kayo Toyosaki, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2025
Nonclinical safety evaluation and pharmacokinetics of Ab612, a novel anti-L1CAM (CD171) therapeutic antibody candidate against solid cancerSe-Ho Kim, Hee Su Chae, Soo Min Ko, et al.
Cancer Immunology, Immunotherapy : CII|October 23, 2025
Identification of two distinct uveal melanoma subtypes based on the immune cell infiltration of the primary tumourKonstantinos Panagiotidis, Sally Owens, Grainne Finegan, et al.
Pageof 651